
Publication|Articles|June 20, 2026
Pharmacy Practice in Focus: Oncology
- June 2026
- Volume 8
- Issue 4
Radiation Recall in Modern Oncology: Evolving Triggers and Treatment
Fact checked by: Kirsty Mackay
This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.
Advertisement
Advertisement
Radiation recall phenomenon (RRP) is an acute inflammatory reaction confined to previously irradiated tissue, triggered by the subsequent administration of systemic anticancer agents, and distinct from concurrent radiosensitization. With the rapid integration of targeted therapies and immune checkpoint inhibitors (ICIs) into oncological practice, the clinical landscape of RRP has shifted, necessitating an updated, evidence-based synthesis of its pathogenesis, contemporary triggers, and optimal management strategies.
Related to this article

Pharmacy Times previews enlicitide, survodutide, diet and heart failure risk, and pharmacist-led HF care ahead of the AHA Scientific Sessions in Chicago.

Experts highlighted recent gene therapy approvals for inherited immune disorders while addressing ongoing challenges in manufacturing, long-term safety, and patient access.

At the 2026 ASTCT Gene Therapy Summit, experts highlighted how chronic pain, psychological challenges, and neurologic complications may persist despite successful treatment.

Two Kidney Week 2026 posters suggest remnant cholesterol–based markers may help stratify CKD severity and cardiovascular death risk on hemodialysis.

CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.

ESMO 2026 lung cancer trials reshape first-line care with tarlatamab maintenance, stronger KRAS G12C results, and TROP2 ADC gains, raising pharmacy monitoring demands.

ESMO 2026 breast cancer updates show ribociclib boosts survival, while immunotherapy and extended endocrine therapy improve end points without longer overall survival.
Advertisement
Advertisement

